Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Carisma Therapeutics Inc CARM

Healthcare Biotechnology
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing its proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. It is developing a pipeline of product candidates, with an initial focus on advancing multiple ex vivo autologous and in vivo CAR-M therapies for the... see more

Recent & Breaking News (NDAQ:CARM)

Sesen Bio News: Berger Montague Investigates Securities Fraud Allegations Against Sesen Bio, Inc. (SESN); Lead Plaintiff Deadline is October 18, 2021

Newsfile September 24, 2021

CLASS ACTION UPDATE for SESN, SAM and WDH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 24, 2021

SESN LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Sesen Bio, Inc.

Newsfile September 24, 2021

Sesen Class Action Reminder

Newsfile September 23, 2021

SESN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 18, 2021 in the Class Action Filed on Behalf of Sesen Bio, Inc. Limited Shareholders

Newsfile September 23, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - SESN

Newsfile September 23, 2021

LAWSUITS FILED AGAINST ATVI, SESN and HNST - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

Accesswire September 23, 2021

Sesen Shareholder Notice

Newsfile September 22, 2021

SESN: Berman Tabacco Alerts Investors with Losses over $50,000 in Sesen Bio, Inc. of Approaching Lead Plaintiff Deadline

Newsfile September 22, 2021

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Sesen Bio, Inc. Investors with Losses to Secure Counsel Before Important October 18 Deadline in Securities Class Action - SESN

PR Newswire September 22, 2021

HAGENS BERMAN Encourages Sesen Bio (SESN) Investors with Significant Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Fraud Class Action

Newsfile September 22, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATVI, SESN and SAM

Accesswire September 22, 2021

SESN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 18, 2021 in the Class Action Filed on Behalf of Sesen Bio, Inc. Limited Shareholders

Newsfile September 21, 2021

Sesen Shareholder Alert

Newsfile September 21, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sesen Bio, Inc. of Class Action Lawsuit and Upcoming Deadline - SESN

Newsfile September 21, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - SESN

Newsfile September 21, 2021

Sesen Bio News: Berger Montague Investigates Securities Fraud Allegations Against Sesen Bio, Inc. (SESN); Lead Plaintiff Deadline is October 18, 2021

Newsfile September 21, 2021

CLASS ACTION UPDATE for ARDX, SESN and WDH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 21, 2021

Lawsuits Filed Against ITRM, VIEW and SESN - Jakubowitz Law Pursues Shareholders Claims

Accesswire September 21, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OTLY, SESN and HNST

Accesswire September 21, 2021